UiPath (PATH) Stock Tumbles 15% on Dramatic Growth Slowdown, Guidance Embeds 'Significant Conservatism' Says Analyst
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/29/2026
- S&P 500 ends lower; chips tumble and Moderna rallies
- SpaceX weighs Starlink mobile service to US consumers, FT reports
- U.S. chip stocks retreat after Apple price hikes stoke fears over AI trade
- Morgan Stanley flags Fed hike risk if unemployment drops below 4%
- UBS trims AI portfolio exposure to semis and hardware after recent rally
UiPath Inc. (PATH) PT Lowered to $40 at Needham & Company
March 31, 2022 6:59 AM EDTNeedham & Company analyst Scott Berg lowered the price target on UiPath Inc. (NYSE: PATH) to $40.00 (from $85.00) while maintaining a Buy rating following Q4 results.
The analyst commented, "PATH reported strong 4QF22 results, with a one point acceleration in ARR growth (+59% Y/Y) to $925mm... More
UiPath Inc. (PATH) PT Lowered to $35 at BofA Securities
March 31, 2022 6:06 AM EDTBofA Securities analyst Brad Sills lowered the price target on UiPath Inc. (NYSE: PATH) to $35.00 (from $50.00) while maintaining a Buy rating.... More
UiPath Inc. (PATH) PT Lowered to $30 at Canaccord Genuity
March 31, 2022 6:02 AM EDTCanaccord Genuity analyst David Hynes Jr. lowered the price target on UiPath Inc. (NYSE: PATH) to $30.00 (from $55.00) while maintaining a Hold rating.... More
UiPath Inc. (PATH) PT Drops 23% to $57.50 at Credit Suisse After Guiding Well Below Consensus
March 31, 2022 5:56 AM EDTCredit Suisse analyst Phil Winslow lowered the price target on UiPath Inc. (NYSE: PATH) to $57.50 (from $75.00) after reporting FQ4 ARR growth accelerating to 59.4% y/y from 57.9% y/y in FQ3. Operating margin increased as well, to 14.5% (vs. consensus 6.6%) from 4.1% y/y in FQ3. However, guidance... More
UiPath Inc. (PATH) PT Lowered to $23 at Wolfe Research
March 31, 2022 5:38 AM EDTWolfe Research lowered its price target on UiPath Inc. (NYSE: PATH) to $23.00 (from $36.00) while maintaining a Peerperform rating.... More
UiPath Inc. (PATH) PT Lowered to $38 at Macquarie
March 31, 2022 5:08 AM EDTMacquarie analyst Frederick Havemeyer lowered the price target on UiPath Inc. (NYSE: PATH) to $38.00 (from $47.00) while maintaining a Outperform rating.... More
UiPath Inc. (PATH) PT Lowered to $35 at Oppenheimer
March 31, 2022 5:03 AM EDTOppenheimer analyst Brian Schwartz lowered the price target on UiPath Inc. (NYSE: PATH) to $35.00 (from $56.00) while maintaining a Outperform rating.... More
UiPath Inc. (PATH) PT Lowered to $41 at Morgan Stanley
March 31, 2022 2:57 AM EDTMorgan Stanley analyst Keith Weiss lowered the price target on UiPath Inc. (NYSE: PATH) to $41.00 (from $74.00) while maintaining a Overweight rating.... More
